NDC 69097-570 – Deferasirox
Deferasirox 360 mg/1 · Granule · Oral
Product NDC69097-570
Product details
- Brand name
- Deferasirox
- Generic name
- Deferasirox
- Labeler
- Cipla USA Inc.
- Dosage form
- Granule
- Route
- Oral
- Marketing category
- ANDA · ANDA215026
- Marketed since
- February 23, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Iron Chelator
Active ingredients
- Deferasirox 360 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69097-570-53 | 30 PACKET in 1 CARTON (69097-570-53) / 1 GRANULE in 1 PACKET | Feb 23, 2022 |
Other Deferasirox products
- 59651-449 Deferasirox 360 mg/1 · Granule · Aurobindo Pharma Limited
- 59651-448 Deferasirox 180 mg/1 · Granule · Aurobindo Pharma Limited
- 59651-447 Deferasirox 90 mg/1 · Granule · Aurobindo Pharma Limited
- 31722-029 Deferasirox 90 mg/1 · Granule · Camber Pharmaceuticals, Inc.
- 31722-030 Deferasirox 180 mg/1 · Granule · Camber Pharmaceuticals, Inc.
- 31722-031 Deferasirox 360 mg/1 · Granule · Camber Pharmaceuticals, Inc.
- 69097-550 Deferasirox 90 mg/1 · Granule · Cipla USA Inc.
- 69097-560 Deferasirox 180 mg/1 · Granule · Cipla USA Inc.
- 45963-455 Deferasirox 250 mg/1 · Tablet, For Suspension · Actavis Pharma, Inc.
- 45963-456 Deferasirox 500 mg/1 · Tablet, For Suspension · Actavis Pharma, Inc.
- 62332-325 Deferasirox 250 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Inc.
- 62332-326 Deferasirox 500 mg/1 · Tablet, For Suspension · Alembic Pharmaceuticals Inc.